Dudnyk
Dudnyk’s revenue increased more than 30% last year as it continued to expand rare disease and oncology work wins from Jazz Pharmaceuticals, Shire, and Merck. Judges admired the agency’s specialty focus, creative work, and strategic thinking. They also applauded the agency’s commitment to its talent as evidenced through various professional development programs and benefits, including college savings funds for employees’ children.
From the October 19, 2017 Issue of MM+M - Medical Marketing and Media
